{
  "paper_metadata": {
    "pmid": "28338000",
    "title": "MAIN TEXT",
    "extraction_summary": "The paper discusses various TTR variants, particularly focusing on A108V and its implications for stability and amyloidosis."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.324C>T",
      "protein_notation": "p.Ala108Val",
      "genomic_position": null,
      "clinical_significance": "benign",
      "patients": {
        "count": 1,
        "demographics": "Portuguese subject, no specific age or sex mentioned",
        "phenotype": "No evident symptoms associated with TTR amyloidosis"
      },
      "penetrance_data": {
        "total_carriers_observed": 1,
        "affected_count": 0,
        "unaffected_count": 1,
        "uncertain_count": null,
        "penetrance_percentage": 0.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "unaffected",
          "phenotype_details": "No evident symptoms associated with TTR amyloidosis",
          "evidence_sentence": "Despite the subject did not exhibit any evident symptom that could be associated with TTR amyloidosis."
        }
      ],
      "functional_data": {
        "summary": "The A108V variant is more stable than WT TTR, with a higher percentage of tetramer observed.",
        "assays": [
          "MALDI mass spectrometry analysis",
          "native PAGE",
          "Isoelectric Focusing (IEF)",
          "equilibrium urea denaturation",
          "high hydrostatic pressure (HHP) assays"
        ]
      },
      "segregation_data": "Not applicable as only one subject is reported.",
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The A108V variant is suggested to be non-pathogenic and stabilizing.",
      "key_quotes": [
        "This variant is more stable than wild type TTR both in vitro and in human plasma.",
        "The results evidenced that in the TTR A108V heterozygote carrier there was a higher percentage of tetramer over total TTR (75.8\u2009\u00b1\u20096.8% tetramer) than in WT control plasma (69.4\u2009\u00b1\u20098.3% tetramer)."
      ]
    },
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.324C>T",
      "protein_notation": "p.Ala108Ile",
      "genomic_position": null,
      "clinical_significance": "likely benign",
      "patients": {
        "count": null,
        "demographics": null,
        "phenotype": null
      },
      "penetrance_data": {
        "total_carriers_observed": null,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": []
      },
      "individual_records": [],
      "functional_data": {
        "summary": "The A108I variant is predicted to be more stable than A108V.",
        "assays": [
          "FoldX computational modeling",
          "equilibrium urea denaturation"
        ]
      },
      "segregation_data": null,
      "population_frequency": null,
      "evidence_level": "moderate",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The A108I variant is engineered and shows potential for increased stability.",
      "key_quotes": [
        "The modelled TTR A108I variant was predicted to be more stable than A108V by FoldX."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 2,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data extracted from the main text."
  }
}